fda glp-1 warning letters october 2025 The sent a letter to the maker of Ozempic and Wegovy over unreported potential side effects. Here's what to know Trends In FDA FY 2025

If a patient receives a GLP-1 medication by mail-order pharmacy, they should refrigerate it immediately upon arrival

The useful question is no longer only how many scripts were supplied? It is: Which patients can access treatment, through which pathway, for which indication, at what cost, with what persistence, and with what outcome

In contrast, the variations in obesity and T2D were genome-wide

By mimicking a hormone in the body called GLP-1, these medications slow down gastric emptying and promote satiety, which makes it easier to stick to a healthy eating plan

Private health insurance companies in the United States often take their cues from Medicare and Medicaid when it comes to deciding whether or not to cover a certain treatment

[Click to Enlarge] As you can see above, the rate of growth has slowed in the past few years, due partly to the substantial number of products that have already been dropped